Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT06148051
Registration number
NCT06148051
Ethics application status
Date submitted
7/11/2023
Date registered
28/11/2023
Date last updated
8/05/2024
Titles & IDs
Public title
AusCADASIL: An Australian Cohort of CADASIL
Query!
Scientific title
AusCADASIL: An Australian Cohort of CADASIL
Query!
Secondary ID [1]
0
0
AusCADASIL
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Cadasil
0
0
Query!
Condition category
Condition code
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
CADASIL cohort -
Control Cohort -
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Online Medical Questionnaire
Query!
Assessment method [1]
0
0
Includes questions on participant's medical history (CADASIL and other), family history, and medication use. Outcome will be used to inform clinical profile
Query!
Timepoint [1]
0
0
Baseline, Year 1, Year 2, Year 3, Year 4
Query!
Primary outcome [2]
0
0
Weight and height will be combined to report BMI in kg/m^2
Query!
Assessment method [2]
0
0
Participants will undergo structured physical examination which will provide further details on their clinical profile.
Query!
Timepoint [2]
0
0
Baseline, Year 1, Year 2, Year 3, Year 4
Query!
Primary outcome [3]
0
0
Blood Pressure
Query!
Assessment method [3]
0
0
Participants will undergo structured physical examination which will provide further details on their clinical profile. Systolic/diastolic blood pressure will be recorded 3 times during the physical examination
Query!
Timepoint [3]
0
0
Baseline, Year 1, Year 2, Year 3, Year 4
Query!
Primary outcome [4]
0
0
Modified Rankin Scale (mRS)
Query!
Assessment method [4]
0
0
Participants will undergo structured physical examination which will provide further details on their clinical profile. Scale from 0-5 (0 no symptoms, 5 severe disability)
Query!
Timepoint [4]
0
0
Baseline, Year 1, Year 2, Year 3, Year 4
Query!
Primary outcome [5]
0
0
National Institute of Health Stroke Scale (NIHSS)
Query!
Assessment method [5]
0
0
Participants will undergo structured physical examination which will provide further details on their clinical profile. Individual items (11) relating to stroke symptoms and disability, for each item 0 indicates normal.
Query!
Timepoint [5]
0
0
Baseline, Year 1, Year 2, Year 3, Year 4
Query!
Primary outcome [6]
0
0
Alphabet required for Trail Making A/B
Query!
Assessment method [6]
0
0
As part of the neuropsychological battery, participants will need to complete the alphabet to inform ability to complete Trail Making tests A and B. These indicate executive function
Query!
Timepoint [6]
0
0
Baseline, Year 1, Year 2, Year 3, Year 4
Query!
Eligibility
Key inclusion criteria
Inclusion criteria:
1. Adults =18 years old
2. Ability to provide written informed consent
* A large-print version is available for individuals with visual impairment
* An easy-to-read version is available for individuals with cognitive difficulties who may require extra support
3. Ability to attend a testing site
4. Ability to complete minimum dataset (medical examination and medical history questionnaire, blood test to determine genetic status and a short (20 minute) neuropsychology assessment).
5. CADASIL participants according to one of the following categories:
1. confirmed diagnosis via genetic testing (NOTCH3 pathogenic variant), OR
2. suspected diagnosis based on medical history and brain MRI, OR
3. first degree relative of participant who is positive for NOTCH3 pathogenic variant
OR 6. Unrelated individual who is negative for the NOTCH3 pathogenic variant, and has no cognitive complaints (i.e. control participant)
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Exclusion criteria:
1. Significant cognitive impairment leading to an inability to provide informed consent.
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
25/11/2023
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
31/03/2027
Query!
Actual
Query!
Sample size
Target
300
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Perminder Sachdev
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The aim of this project is to establish an Australian cohort of patients diagnosed with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). This study will examine the clinical features and longitudinal course of CADASIL. Outcome measures include neuropsychological profile, neuroimaging, genetics, blood biomarkers, and retinal imaging.
Query!
Trial website
https://clinicaltrials.gov/study/NCT06148051
Query!
Trial related presentations / publications
Query!
Public notes
This record is viewable in the ANZCTR as it had previously listed Australia and/or New Zealand as a recruitment site, however these sites have since been removed
Query!
Contacts
Principal investigator
Name
0
0
Perminder S Sachdev, MBBS, MD, PhD, FRANZCP, FAAHMS
Query!
Address
0
0
University of New South Wales
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Danit Saks, MBMSc, MRes, PhD
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
9348 1658
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT06148051
Download to PDF